Negev Labs Unveils Next-Gen Psychedelic Therapies with Non-Hallucinogenic Neuroplastogens

Negev Labs Emerges from Stealth:
Negev Labs, a biotechnology company builder, has emerged from stealth with a focus on developing neuroplastogens, a novel class of psychedelic-based therapeutics that lack hallucinogenic effects13.

Licensing Agreement with ASRI:
Negev Labs has entered into a licensing agreement with the Alexander Shulgin Research Institute (ASRI), gaining access to a vast library of drug candidates originally discovered by Alexander Shulgin, a renowned chemist in psychedelic drug development1.

Acquisition of Beckley Psytech’s Ophthalmology Program:
Negev Labs has acquired Beckley Psytech’s Ophthalmology development program, aligning with its mission to explore the therapeutic potential of neuroplastogens in various disorders, including retinal degeneration1.

R&D Collaboration with Hadassah Brain Labs:
Negev Labs collaborates with the Hadassah Brain Labs Center for Psychedelic Research to develop innovative treatments that overcome the limitations of first-generation psychedelic therapies1.

Focus on Non-Hallucinogenic Neuroplastogens:
The company focuses on developing non-hallucinogenic neuroplastogens that retain therapeutic efficacy while minimizing hallucinogenic effects, addressing critical challenges in the field12.

Potential for Mental Health Treatments:
Neuroplastogens show promise in treating psychiatric, neurological, and inflammatory disorders, offering a new approach to addressing unmet clinical needs in mental health125.

Growing Interest in Neuroplastogens:
The debut of Negev Labs comes amidst growing interest in neuroplastogens, particularly as traditional psychedelic front-runners face developmental hurdles3.

Sources:

1. https://www.prnewswire.com/news-releases/negev-labs-emerges-from-stealth-with-announcement-of-alexander-shulgin-research-institute-licensing-agreement-acquisition-of-beckley-psytech-development-program-and-rd-collaboration-with-hadassah-brain-labs-center-for-psychedeli-302328988.html

2. https://news.uchicago.edu/psychedelics-without-hallucinations-new-mental-health-treatment

3. https://c.firstwordpharma.com/firstwordgroup/assets/images/drugspsychiatric.jpg?sa=X&ved=2ahUKEwjHvpzC8amKAxUxkIkEHeAGMpwQB16BAgCEAI

5. https://www.massgeneral.org/psychiatry/treatments-and-services/center-for-the-neuroscience-of-psychedelics